No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
424 |
4. Check minimum number of eventsNone |
424 |
5. Include endpointsNone |
424 |
6. Filter based on genotype QC (FinnGen only) |
383 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D32
- Name in latin
- Neoplasma benignum meningum spinalium
Benign neoplasm: Spinal meninges
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2153 | 1510 | 634 |
| Only index persons | 1841 | 1306 | 535 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 62.54 | 63.92 | 59.41 |
| Only index persons | 61.91 | 63.16 | 58.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 383 | 280 | 103 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.05 |
| Median age at first event (years) | 62.99 | 62.93 | 63.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 395
- Matched controls
- 3950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
307.7
370
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
225.3
194
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
65.5
169.1
95
19
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
90.1
83
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
32.1
79.7
53
19
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
29.6
79.1
54
21
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
17.3
57.2
49
32
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
78.2
53.9
60
9
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
11.7
50.4
55
54
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.5
50.4
98
192
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
15.9
39.6
35
24
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
209.6
37.5
38
*
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
135.7
35.3
37
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.4
33.5
61
110
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
78.8
32.5
36
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.9
31.8
119
389
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
27.8
28.1
38
15
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
277.8
26.0
26
*
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
100.2
26.0
28
*
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
24.2
23
*
2254A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
23.1
22
*
N03AX12
ATC
[U] gabapentin; oral
3.2
23.0
116
450
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
+∞
22.1
21
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
21.8
97
348
D33.43
ICD-10 Finland
Spinal cord
+∞
21.0
20
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
20.5
150
709
8000/0-C70.1
ICD-O-3
Neoplasm, benign of spinal meninges
+∞
20.0
19
*
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
210.1
19.7
20
*
N03AX16
ATC
[U] pregabalin
2.7
19.3
142
670
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
18.9
18
*
2312
FHL
Extirpation or destruction
+∞
18.9
18
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
177.2
16.6
17
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.9
16.6
53
151
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
14.6
15.7
26
19
G992, D321,
ICD-10 Finland
+∞
15.7
15
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
15.7
15
*
G82.2
ICD-10 Finland
Paraplegia, unspecified
23.2
15.7
22
10
R20.2
ICD-10 Finland
Paraesthesia of skin
3.7
15.5
53
158
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
15.1
74
277
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
14.7
64
223
N75
ICPC
Benign neoplasm nervous system
+∞
14.7
14
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
44.2
14.2
17
*
L28
ICPC
Limited function/disability (L)
2.4
14.0
123
617
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.3
14.0
24
40
9531/0-C70.1
ICD-O-3
Meningothelial meningioma of spinal meninges
+∞
13.6
13
*
N18
ICPC
Paralysis/weakness
6.4
13.1
22
36
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.9
13.0
24
43
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.3
12.9
35
88
M03BX01
ATC
baclofen; systemic
5.9
12.6
23
41
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
134.1
12.5
13
*
9537/0-C70.1
ICD-O-3
Transitional meningioma of spinal meninges
+∞
11.5
11
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
16.1
10.9
17
11
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
11.0
10.9
20
19
N06AX21
ATC
duloxetine; oral
2.6
10.7
71
309
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.6
10.7
26
60
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.6
10.5
20
37
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
10.5
10
*
D42.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal meninges
+∞
10.5
10
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.4
10.3
26
62
R4110
NOMESCO Finland
Physiotherapy
2.1
10.2
142
843
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
10.0
50
188
XKD00
NOMESCO Finland
Uroflowmetry
2.5
9.8
67
295
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
9.4
9
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
9.4
9
*
N06AA09
ATC
amitriptyline; systemic
2.5
8.8
59
257
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
51.1
8.7
10
*
D33.30
ICD-10 Finland
Acoustic neuroma
16.7
8.6
13
8
N02AX02
ATC
tramadol; systemic, rectal
1.9
8.5
192
1325
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
91.9
8.4
9
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
91.9
8.4
9
*
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
8.4
8
*
22540
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
8.4
8
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
+∞
8.4
8
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
8.4
8
*
N02BF01
ATC
gabapentin; oral
2.4
8.2
63
292
N03AX14
ATC
levetiracetam; systemic
4.7
8.2
19
42
N28
ICPC
Limited function/disability (N)
6.5
8.1
20
32
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
8.1
91
494
WX402
NOMESCO Finland
General anaesthesia
2.0
8.1
102
578
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
8.1
98
548
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
7.9
43
169
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
7.7
59
273
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
25.6
7.6
10
*
N02BF02
ATC
pregabalin; oral
2.7
7.5
42
167
M48.0
ICD-10 Finland
Spinal stenosis
2.2
7.5
73
374
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
81.6
7.4
8
*
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
81.6
7.4
8
*
XKC03
NOMESCO Finland
Water cystometry
3.6
7.4
24
69
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
7.3
7
*
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
4.4
7.3
18
42
N02BE01
ATC
paracetamol; systemic, rectal
3.0
7.2
369
3266
AA1AD
NOMESCO Finland
CT of head and brain
1.8
7.2
140
910
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
30.6
7.2
9
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
20.5
7.2
10
5
M54.2
ICD-10 Finland
Cervicalgia
2.6
7.1
43
179
ZXD35
NOMESCO Finland
Usual procedure
3.8
7.0
21
57
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
6.9
160
1096
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
23.0
6.7
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.7
80
443
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
10.3
6.6
12
12
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.5
6.5
22
65
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.3
6.4
24
76
9539/1-C70.1
ICD-O-3
Atypical meningioma of spinal meninges
+∞
6.3
6
*
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
6.3
6
*
9533/0-C70.1
ICD-O-3
Psammomatous meningioma of spinal meninges
+∞
6.3
6
*
AAK00
NOMESCO Finland
Cranioplasty
+∞
6.3
6
*
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
27.1
6.2
8
*
ABC63
NOMESCO Finland
Decompression of thoracic spinal cord
27.1
6.2
8
*
H02AB02
ATC
dexamethasone; systemic
2.1
6.2
63
328
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
6.1
282
2308
ZXC40
NOMESCO Finland
Use of ultrasound
12.8
6.1
10
8
M54.6
ICD-10 Finland
Pain in thoracic spine
2.5
6.0
39
167
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
109
471
2.82
17.30
4.6
6.6
0.59
1.04
mmol/l
0.58
83
401
302
2175
2.65
15.39
5.8
4.8
6.42
6.68
mmol/l
1.76
290
2058
26
22
12.56
14.79
1.8
1.8
—
—
—
0
0
67
244
3.10
14.30
4.5
7.6
24.22
24.45
mmol/l
0.28
67
239
151
884
2.15
11.55
2.9
2.3
—
—
—
0
0
272
1991
2.18
11.43
7.3
6.6
1.21
1.21
mmol/l
0.43
235
1718
184
1211
1.97
9.83
2.7
2.1
202.50
171.48
u/l
0.22
171
1149
232
1683
1.92
8.98
3.5
2.7
—
—
estimate
—
0
0
244
1812
1.91
8.66
6.7
6.0
1.21
1.21
mmol/l
0.76
222
1667
14
11
13.14
8.43
2.9
1.0
—
—
—
0
0
93
552
1.90
6.30
4.2
5.9
105.28
104.13
mmol/l
1.65
93
552
29
105
2.90
6.20
1.7
1.5
—
—
—
0
0
228
1782
1.66
5.67
15.9
14.4
1.19
1.24
inr
0.93
194
1451
62
335
2.01
5.49
1.9
2.8
66.40
66.56
g/l
0.06
52
306
65
362
1.95
5.28
4.6
6.0
1.18
1.34
mmol/l
0.78
65
356
221
1734
1.62
5.24
5.6
4.5
35.41
35.41
g/l
0.00
212
1630
34
153
2.34
4.75
1.3
1.9
9.07
10.56
g/l
2.41
26
135
12
22
5.59
4.63
2.3
1.9
—
—
—
0
0
7
6
11.84
4.29
1.1
1.7
—
—
—
0
0
36
175
2.16
4.21
1.4
2.0
4.08
4.27
g/l
0.54
28
158
36
175
2.16
4.21
1.4
2.0
7.20
7.54
g/l
0.36
28
158
36
175
2.16
4.21
1.3
2.0
3.44
3.83
g/l
0.85
28
158
34
163
2.19
4.12
1.4
2.1
2.88
3.06
g/l
0.31
26
146
309
2705
1.65
4.11
5.7
4.6
14.63
13.47
mm/h
0.53
292
2496
167
1283
1.52
3.98
3.6
3.5
27.33
109.58
e6/l
0.91
123
991
214
1734
1.51
3.95
2.3
2.2
98.25
96.77
pmol/l
0.14
108
869
153
1162
1.52
3.81
3.5
2.4
54.09
69.62
u/l
1.60
141
1065
76
493
1.67
3.70
5.1
4.8
1.07
1.03
mmol/l
0.83
69
452
210
1712
1.48
3.66
2.7
2.6
79.84
80.01
nmol/l
0.03
191
1521
90
613
1.61
3.61
3.1
3.3
1.91
2.67
e6/l
0.60
45
291
153
1177
1.49
3.53
1.7
1.7
20.96
21.73
nmol/l
0.22
126
989
97
679
1.57
3.46
3.0
3.1
1.15
1.04
e6/l
0.08
54
358
11
27
4.16
3.42
1.7
2.5
—
—
—
0
0
236
1986
1.47
3.39
7.9
6.3
11.70
11.30
umol/l
0.07
224
1883
98
691
1.56
3.38
1.9
1.7
1107.10
1218.18
nmol/l
0.61
71
510
27
129
2.17
3.32
1.7
2.0
—
—
—
0
0
61
385
1.69
3.28
2.7
2.0
347.46
381.53
nmol/l
0.68
56
361
10
24
4.25
3.21
1.9
1.3
180.50
74.99
ng/l
—
10
24
20
85
2.43
3.20
1.8
1.1
67.45
15.11
e6/l
0.44
11
62
25
119
2.18
3.11
1.8
1.8
—
—
—
0
0
20
87
2.37
3.06
1.9
1.1
1216.31
153.82
e6/l
0.66
13
66
242
2070
1.44
3.03
10.5
9.6
4.14
4.12
e9/l
0.05
203
1800
7
12
5.92
3.03
1.3
1.0
—
—
—
0
0
142
1103
1.45
3.02
3.7
3.4
0.68
0.51
e6/l
0.36
100
812
254
2193
1.44
3.02
4.4
3.2
43.40
46.54
u/l
0.39
240
2034
173
1396
1.43
2.99
3.5
3.5
2.35
2.36
mmol/l
0.55
158
1261
19
82
2.38
2.96
2.1
1.5
—
—
—
0
0
13
46
2.89
2.94
1.2
1.5
—
—
—
0
0
13
46
2.89
2.94
1.2
1.5
—
—
—
0
0
13
47
2.83
2.84
1.2
1.5
—
—
—
0
0
13
47
2.83
2.84
1.2
1.5
—
—
—
0
0
149
1180
1.42
2.82
3.2
3.1
28.45
29.90
u/l
0.27
136
1110
29
153
1.97
2.79
1.6
2.3
0.46
0.84
g/l
0.37
21
133
360
3365
1.79
2.78
24.9
17.1
21.15
24.24
mg/l
1.45
334
2772
13
48
2.77
2.74
1.2
1.5
—
—
—
0
0
13
48
2.77
2.74
1.2
1.5
—
—
—
0
0
126
974
1.43
2.71
3.0
2.2
3.16
3.03
mg/l
0.25
109
836
8
19
4.27
2.69
1.9
3.1
631.88
901.11
u/ml
—
8
19
65
441
1.57
2.63
7.0
7.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
15
4.73
2.61
1.1
1.1
—
—
—
0
0
307
2779
1.47
2.60
11.1
8.2
78.87
79.28
u/l
0.06
294
2613
45
285
1.65
2.41
1.8
1.6
—
—
—
0
0
13
53
2.50
2.30
1.2
1.2
—
—
—
0
0
58
397
1.54
2.27
3.5
2.6
4.98
6.88
umol/l
1.97
52
350
55
375
1.54
2.19
3.7
3.7
—
—
—
0
0
9
30
3.05
2.16
1.0
1.1
—
—
—
0
0
59
414
1.50
2.06
3.9
3.2
5.71
5.76
kpa
0.17
59
401
21
111
1.94
2.05
1.5
1.4
28.54
27.41
iu/l
0.05
21
92
12
50
2.44
2.04
1.5
1.8
89.31
90.02
%
0.18
12
50
86
653
1.41
2.00
2.4
2.0
—
—
—
0
0
13
57
2.32
2.00
1.3
1.3
—
—
—
0
0
113
899
1.36
1.98
2.9
2.8
4.80
6.30
e6/l
0.65
102
828
108
854
1.36
1.96
3.1
2.8
2.45
2.46
mmol/l
0.21
99
766
83
633
1.39
1.88
2.9
2.4
11.08
12.80
umol/l
1.33
73
592
24
138
1.79
1.84
1.3
2.0
0.00
0.04
g/l
0.50
19
124
22
124
1.82
1.80
1.3
2.1
0.00
0.00
g/l
-0.00
17
115
101
802
1.35
1.78
2.0
1.8
471.29
25574721.04
pmol/l
0.72
83
653
6
18
3.37
1.75
1.0
1.3
—
—
—
0
0
30
187
1.65
1.75
1.4
1.4
—
—
—
0
0
21
118
1.82
1.74
1.1
1.3
—
—
—
0
0
8
30
2.70
1.73
1.6
1.0
—
—
—
0
0
348
3297
1.47
1.69
22.3
17.2
78.50
76.59
ml/min/173m2
0.97
329
3059
18
97
1.90
1.69
1.8
1.8
3.63
4.84
iu/l
—
6
38
189
1648
1.28
1.66
3.7
3.0
141.98
112.78
ug/l
0.62
176
1513
8
31
2.61
1.66
1.6
1.0
—
—
—
0
0
7
25
2.83
1.65
1.6
1.0
—
—
—
0
0
31
200
1.60
1.59
4.0
3.6
3.30
2.26
mmol/l
0.83
22
154
224
2003
1.27
1.58
5.1
4.3
0.00
0.01
estimate
0.69
42
382
19
107
1.81
1.57
1.5
1.3
—
—
—
0
0
30
194
1.59
1.53
3.6
3.8
1.02
1.02
ratio
0.29
25
182
49
355
1.43
1.49
2.2
2.3
33.60
30.07
u/l
0.33
42
291
35
237
1.52
1.48
1.9
1.8
—
—
—
0
0
66
506
1.37
1.45
2.5
1.9
—
—
—
0
0
13
66
2.00
1.45
1.8
2.0
42.92
44.61
nmol/l
0.08
13
66
9
39
2.34
1.44
1.1
1.6
—
—
—
0
0
22
134
1.68
1.42
1.3
2.0
0.00
0.00
g/l
-0.00
17
116
48
352
1.41
1.38
2.3
2.1
0.20
0.21
g/l
0.22
40
332
6
24
2.52
1.31
1.0
1.2
145.33
105.62
pmol/l
—
6
24
17
100
1.73
1.25
3.8
3.1
16.50
1.75
index
—
8
53
104
869
1.27
1.25
1.4
1.3
0.89
1.42
u/ml
0.57
22
216
20
124
1.65
1.23
1.6
4.0
1.47
2.63
ratio
0.98
13
67
79
639
1.30
1.22
2.5
2.8
0.84
0.81
mmol/l
1.62
70
600
129
1108
1.24
1.22
5.4
4.4
0.00
0.01
estimate
0.50
42
371
168
1485
1.23
1.21
4.4
4.0
32.53
54.24
ng/l
0.46
133
1120
102
855
1.26
1.19
1.9
1.7
1.02
1.31
mg/l
0.73
83
689
6
26
2.33
1.19
1.0
1.2
—
—
—
0
0
8
38
2.13
1.19
1.0
1.0
—
—
—
0
0
218
1983
1.22
1.18
4.9
4.3
0.00
8.46
estimate
0.80
45
414
209
1895
1.22
1.16
2.7
2.7
—
—
—
0
0
341
3262
1.33
1.16
7.4
7.0
39.44
39.63
mmol/mol
0.16
314
3037
216
1966
1.22
1.15
4.9
4.3
0.00
0.00
estimate
-0.00
45
405
5
21
2.40
1.09
1.4
4.4
56.80
168.67
nmol/l
—
5
21
41
307
1.37
1.07
2.2
2.7
56.79
63.74
ml/min/173m2
0.50
14
127
10
52
1.95
1.07
3.4
2.8
22.20
17.38
mg/l
—
5
19
60
477
1.30
1.06
5.6
5.2
34.61
32.89
%
0.55
38
297
5
22
2.29
1.03
1.0
1.4
—
—
—
0
0
5
22
2.29
1.03
1.0
1.4
—
—
—
0
0
5
22
2.29
1.03
1.0
1.4
78.00
73.18
umol/l
—
5
22
337
3233
1.29
1.00
6.7
5.7
1.80
1.96
mu/l
1.91
311
2956
56
447
1.29
0.97
3.2
4.2
2.79
18.73
ug/l
1.03
45
374
6
119
0.50
0.95
1.2
1.5
—
—
—
0
0
7
37
1.91
0.94
1.6
1.6
—
—
—
0
0
71
591
1.25
0.89
2.9
2.4
2.26
2.32
g/l
0.31
62
552
8
43
1.88
0.88
1.1
1.2
—
—
—
0
0
10
57
1.77
0.84
2.1
2.7
—
939.17
—
0
6
8
47
1.72
0.81
4.0
4.1
—
—
—
0
0
40
316
1.30
0.77
3.1
2.6
3.29
4.93
ug/l
1.57
35
280
364
3549
1.33
0.77
16.1
12.8
25.69
24.38
u/l
0.34
356
3435
148
1339
1.17
0.77
3.3
3.2
6.26
7.01
mmol/l
1.66
123
1107
66
555
1.23
0.76
3.0
2.4
20.73
22.31
%
0.35
56
525
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
85
735
1.20
0.75
5.7
5.8
2.62
2.48
ug/l
0.09
76
660
140
1265
1.17
0.73
3.3
3.2
1376.81
1181.07
ng/l
0.25
130
1086
86
746
1.20
0.73
5.0
4.1
122.19
197.12
ng/l
0.31
72
608
17
118
1.46
0.70
6.2
4.0
26.26
25.44
mmol/l
0.40
17
112
25
187
1.36
0.70
5.2
3.1
24.79
25.14
mmol/l
0.18
25
182
146
1331
1.15
0.68
4.0
4.0
13.04
7.22
mg/mmol
0.46
88
781
7
44
1.60
0.65
1.4
1.3
—
81.83
—
0
6
82
720
1.18
0.62
1.4
1.3
31.08
38.25
iu/ml
0.22
30
211
32
256
1.27
0.59
4.4
2.8
123.16
127.40
g/l
0.68
32
248
15
106
1.43
0.58
2.3
2.4
1.34
1.50
mg/l
0.34
15
93
6
35
1.73
0.58
1.7
1.7
—
—
—
0
0
5
88
0.56
0.56
1.6
1.8
—
—
—
0
0
13
90
1.46
0.56
1.4
1.3
—
—
—
0
0
6
37
1.63
0.56
1.3
1.4
42.10
38.12
u/l
—
6
31
17
127
1.35
0.50
1.2
1.4
0.22
0.27
mg/l
—
5
53
16
119
1.36
0.49
1.9
1.3
282.09
307.21
ug/g
0.19
11
70
14
102
1.39
0.48
1.3
1.2
—
—
—
0
0
15
111
1.37
0.47
2.3
1.6
6781.70
20595.69
e6/l
—
10
75
7
49
1.44
0.46
1.9
1.3
—
—
—
0
0
37
313
1.20
0.44
1.6
1.4
—
—
—
0
0
342
3350
1.16
0.41
6.0
5.6
5.88
5.97
mmol/l
1.01
312
3054
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
66
591
1.14
0.40
4.7
5.0
22.35
21.88
%
0.09
28
300
95
1031
0.90
0.39
4.9
3.8
0.00
0.00
estimate
0.50
39
326
50
440
1.16
0.39
3.0
3.3
1.05
0.76
ug/l
0.33
33
291
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
54
480
1.14
0.37
2.7
2.0
—
—
—
0
0
5
37
1.36
0.37
1.2
1.2
10.86
7.47
mmol/l
—
5
28
286
2790
1.09
0.30
5.5
4.5
15.09
14.93
pmol/l
0.47
263
2529
21
176
1.20
0.29
1.8
2.1
3.27
6.68
iu/ml
—
6
47
8
107
0.74
0.29
1.8
2.1
168.50
207.14
%
—
8
102
366
3618
1.16
0.28
37.0
26.3
4.38
4.41
e12/l
0.58
361
3524
9
120
0.74
0.27
1.6
1.2
—
—
—
0
0
9
120
0.74
0.27
1.6
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
104
1.26
0.26
1.8
2.4
0.23
0.38
iu/ml
—
7
59
14
171
0.81
0.26
1.5
1.3
—
—
—
0
0
8
67
1.20
0.26
1.8
1.6
—
—
—
0
0
9
76
1.19
0.25
3.4
1.4
—
—
—
0
0
9
76
1.19
0.25
3.4
1.4
—
—
—
0
0
149
1553
0.93
0.24
2.0
2.0
1.42
1.32
mmol/l
1.00
129
1285
6
84
0.71
0.24
1.2
1.2
1.50
1.59
g/l
—
6
84
0
11
0.00
0.21
0.0
1.1
—
84.83
—
0
6
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
122.91
—
0
11
0
11
0.00
0.21
0.0
1.1
—
96.00
—
0
6
0
10
0.00
0.21
0.0
1.0
—
23.02
—
0
10
8
104
0.76
0.21
2.5
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
0.18
—
0
12
26
230
1.14
0.21
3.2
2.3
0.57
0.62
%
0.60
26
230
6
52
1.16
0.19
1.3
1.1
—
300.80
—
0
5
56
597
0.93
0.17
1.5
1.4
—
—
—
0
0
8
68
1.18
0.16
1.5
1.7
—
—
—
0
0
26
235
1.11
0.16
3.2
2.3
1.07
1.16
%
0.25
26
235
15
130
1.16
0.16
1.1
1.3
—
—
—
0
0
7
86
0.81
0.14
1.3
1.5
—
—
—
0
0
7
87
0.80
0.14
1.1
1.2
0.82
0.90
g/l
—
7
87
56
530
1.07
0.14
1.5
1.5
—
—
—
0
0
95
915
1.05
0.13
3.3
2.8
330.19
336.94
umol/l
0.25
84
782
85
884
0.95
0.13
5.1
4.4
1.02
1.02
kg/l
0.49
57
588
12
104
1.16
0.12
1.7
1.6
—
—
—
0
0
15
134
1.12
0.11
2.3
2.9
—
—
—
0
0
344
3417
1.05
0.09
6.5
6.4
2.68
2.67
mmol/l
0.06
317
3125
12
134
0.89
0.09
1.7
1.6
—
—
—
0
0
63
652
0.96
0.08
1.4
1.3
2.14
13.11
u/ml
3.19
28
238
14
127
1.11
0.08
1.6
1.2
—
1.14
—
0
5
7
85
0.82
0.07
2.3
2.0
—
—
—
0
0
9
88
1.02
0.07
1.0
1.4
—
—
—
0
0
273
2746
0.98
0.04
31.2
22.9
330.79
330.78
g/l
0.00
273
2731
25
260
0.96
0.03
2.0
2.1
3.34
3.40
ratio
0.08
20
219
12
112
1.07
0.03
1.7
1.6
—
—
—
0
0
336
3350
1.02
0.02
5.7
5.5
4.63
4.65
mmol/l
0.11
311
3075
25
242
1.04
0.02
1.2
1.2
87.33
130.77
u/ml
—
8
90
10
93
1.08
0.02
1.8
1.4
—
—
—
0
0
319
3199
0.99
0.02
4.8
4.5
1.27
1.26
mmol/l
0.07
284
2892
333
3338
0.98
0.01
5.7
5.4
1.50
1.53
mmol/l
0.46
304
3049
22
213
1.03
0.01
1.5
2.1
—
—
—
0
0
10
106
0.94
0.01
1.7
1.3
—
—
—
0
0
23
224
1.03
0.00
6.8
3.4
49.14
49.53
%
0.02
23
219
32
322
0.99
0.00
1.5
1.6
1.44
1.51
%
0.32
26
279
20
199
1.01
0.00
1.5
1.9
—
—
—
0
0
148
1478
1.00
0.00
5.3
4.3
0.00
0.03
estimate
1.47
41
335
11
105
1.05
0.00
1.4
1.8
—
—
—
0
0
18
185
0.97
0.00
1.1
1.0
—
—
—
0
0
11
114
0.96
0.00
2.0
1.3
—
—
—
0
0
20
196
1.02
0.00
1.9
1.9
3.29
3.37
mmol/l
0.12
15
156
8
82
0.98
0.00
1.8
1.5
—
—
—
0
0
8
82
0.98
0.00
3.4
2.5
8.06
8.80
pmol/l
—
8
82
7
75
0.93
0.00
1.0
1.2
1.09
0.90
nmol/l
—
7
58
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
116.33
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
97
0.93
-0.00
1.3
1.2
—
28.16
—
0
12
0
7
0.00
-0.00
0.0
3.7
—
75.57
—
0
7
0
6
0.00
-0.00
0.0
2.0
—
1.19
—
0
6
9
97
0.93
-0.00
1.7
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.6
2.4
1.19
1.19
mmol/l
—
5
52
5
52
0.96
-0.00
1.6
2.4
106.00
105.94
mmol/l
—
5
52
5
51
0.98
-0.00
1.2
1.1
—
—
—
0
0
5
51
0.98
-0.00
1.2
1.5
—
—
—
0
0
5
50
1.00
-0.00
1.6
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MENINGES_SPINAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES_SPINAL | 1.32 [1.11, 1.57] | 0.002 |
| Birth year | 0.995 [0.99, 1.0] | 0.287 |
During the follow-up period (1.1.1998 — 31.12.2019), 262 out of 1097 females with CD2_BENIGN_MENINGES_SPINAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES_SPINAL | 1.558 [1.19, 2.03] | 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 132 out of 448 males with CD2_BENIGN_MENINGES_SPINAL died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MENINGES_SPINAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.339% |
| 5 | 0.788% | 1.945% |
| 10 | 2.149% | 4.442% |
| 15 | 3.812% | 8.205% |
| 20 | 6.545% | 13.631% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MENINGES_SPINAL – Benign neoplasm: Spinal meninges
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data